Sanara MedTech Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Seth D. Yon
- Full Time Employees
- 108
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 1200 Summit Avenue Fort Worth TX United States of America 76102
- IPO Date
- Apr 7, 1994
- CIK
- 0000714256
- Website
- sanaramedtech.com
- Similar Companies
- Business
- Sanara MedTech Inc. (NASDAQ: SMTI), a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings primarily in the United States. Founded in 2001 and headquartered in Fort Worth, Texas, the company offers CellerateRX Surgical Activated Collagen Powder, a hydrolyzed Type I bovine collagen for surgical, traumatic, and burn wounds; BIASURGE Advanced Surgical Solution, a no-rinse antimicrobial irrigation solution; FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix, both porcine small intestinal submucosa-based products for soft tissue reinforcement; TEXAGEN Amniotic Membrane Allograft, a multilayer barrier for wounds; ALLOCYTE Plus Advanced Viable Bone Matrix, a cellular bone allograft; BiFORM Bioactive Moldable Matrix, an osteoconductive bone graft; ACTIGEN Verified Inductive Bone Matrix, a differentiated allograft; BIAKŌS Antimicrobial Skin and Wound Cleanser, Gel, and Irrigation Solution; and HYCOL Hydrolyzed Collagen for chronic wound care. Sanara MedTech recently secures a $55 million non-dilutive debt facility from CRG Servicing LLC in April 2024 to fund growth initiatives, permitted acquisitions, and working capital, with $15 million drawn initially and up to $40 million more available through June 2025; enters an exclusive U.S. distribution agreement with InfuSystem Holdings Inc. for ChemoMouthpiece oral cryotherapy device in September 2024, accompanied by a $5 million investment for 6.6% ownership to expand skincare offerings for oncology patients; and reports third-quarter 2025 net revenue of $26.3 million, up 22% from the prior year, alongside expansions into virtual wound and skin care telemedicine services.
Company News
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—FBRX, LXFR, SMTI, and MKTX
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--FBRX, LXFR, SMTI, and MKTX
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger—FBRX, LXFR, SMTI, and MKTX
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)
Are MKTX, SMTI, LPSN Obtaining Fair Deals for their Shareholders?
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sanara MedTech Inc. (NASDAQ: SMTI)
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)
Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders
Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
MIMEDX to Acquire Sanara MedTech
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI